Our New Super Low Float For The Week Is IMD Companies, Inc. (OTC: ICBU )

Botanical Science is a nutraceutical company founded in 2009, with a product line focused on weight control and the overall health of the consumer. The company has several product formulations available as digestible strips, a very innovative and convenient delivery method, which also offers the benefit of quicker absorption when compared to capsule supplements. iMD is focused on boosting revenue by expanding the existing product line, introducing its own line of nutrition bars and meal replacement shakes, and growing distribution through physicians' offices and directly to consumers. www.botanicalscience.com

The KidShape program is a comprehensive juvenile weight-loss system that has a history of success combating childhood and teen obesity. The KidShape curriculum has been in use for over five years and is well recognized in pediatric obesity treatment circles. iMD will use the KidShape programs in conjunction with Positive Solutions Centers to provide a turnkey solution to physicians, clinics, and other institutions focused on addressing the current juvenile and pediatric obesity epidemic. KidShape programs are also suited for and intended to be used in governmental programs and public and private school systems. www.kidshape.net

Positive Solutions has reached an agreement to acquire a turn-key licensing and franchising business, along with substantial intellectual property, for the medical treatment of adult weight loss from Jay J. Garcia, MD. In addition to nutritional plans, medical protocols, operating procedures, custom software, a patient health portal, and seven years of obesity treatment data, Dr. Garcia and several key members of his staff will be joining the company. Positive Solutions already has licensees treating patients, several more physicians in the process of becoming licensees, and we anticipate the rapid expansion of additional licensees for this safe, effective program for the treatment of obesity and obesity-related conditions. www.pscenters.com

Hyper-Interactive Marketing serves several key roles for the corporation. First, it provides business valuations, strategic consulting, and funding for early-stage growth companies. We are able to leverage the talent pool of management, the infrastructure of shared services, and the strength of the public company in order to provide or secure funding for companies in which iMD takes a significant equity stake. Second, Hyper-Interactive Marketing is cultivating the expertise and infrastructure to exploit the latest trends toward social media and its use in building brands and successful marketing campaigns. Finally, recognizing that self-esteem and personal appearance is an important part of overall emotional wellness, Hyper-Interactive Marketing is investing in the development of several different brands offering personal hygiene products, cosmetics, and other personal image goods and services focused on gaining significant traction through the use of celebrity licensing agreements and social media marketing efforts. www.hypmtg.com

Optimum Mobile Imaging began in 2006 with a focus on delivering state-of-the-art mobile imaging technology to patients in Arizona. The company has grown its capabilities, with the intention of bringing the highest levels of quality and the latest available ultrasound imaging technology right to the door of existing offices and clinics. Patients receive services right in their local physician's office or clinic. Services provided by OMI are generally covered by insurance. The company's designation as an Independent Diagnostic Testing Facility (IDTF) permits reimbursement by Medicare and has allowed OMI to contract with private insurance providers nationwide. www.omiaz.com

PCI HeartScan utilizes state-of-the-art ultrasound images and sophisticated quantitative analyses to provide a highly sensitive assessment of cardiovascular functioning. The quantitative information allows for the detection of cardiac disease in the earliest stages and for the objective evaluation of the treatment of cardiovascular disease over time. The algorithms used by PCI HeartScan are based on the findings of twenty years of research and over 100,000 subjects to determine the risks of strokes and heart attacks. Their own database is comprised of over 45,000 studies, including 8,000 studies of the same subjects over time. Due to this extensive experience, PCI HeartScan has developed protocols and procedures to deliver accurate, reliable, reproducible results in a very cost-effective manner. www.pciheartscan.com

News & Events